nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP3A4—Pilocarpine—glaucoma	0.0642	0.235	CbGbCtD
Trametinib—CYP3A4—Brinzolamide—glaucoma	0.0504	0.185	CbGbCtD
Trametinib—CYP3A4—Dorzolamide—glaucoma	0.0487	0.178	CbGbCtD
Trametinib—CYP3A4—Methazolamide—glaucoma	0.0434	0.159	CbGbCtD
Trametinib—CYP3A4—Acetazolamide—glaucoma	0.0347	0.127	CbGbCtD
Trametinib—CYP3A4—Clonidine—glaucoma	0.0314	0.115	CbGbCtD
Trametinib—Stomatitis—Betaxolol—glaucoma	0.000546	0.00125	CcSEcCtD
Trametinib—Dry mouth—Brinzolamide—glaucoma	0.000545	0.00125	CcSEcCtD
Trametinib—Vomiting—Methazolamide—glaucoma	0.000545	0.00125	CcSEcCtD
Trametinib—Oedema—Dorzolamide—glaucoma	0.000544	0.00124	CcSEcCtD
Trametinib—Hypertension—Pilocarpine—glaucoma	0.000543	0.00124	CcSEcCtD
Trametinib—Gastrointestinal pain—Apraclonidine—glaucoma	0.000542	0.00124	CcSEcCtD
Trametinib—Abdominal pain upper—Timolol—glaucoma	0.000542	0.00124	CcSEcCtD
Trametinib—Oedema—Travoprost—glaucoma	0.000541	0.00124	CcSEcCtD
Trametinib—Rash—Methazolamide—glaucoma	0.00054	0.00124	CcSEcCtD
Trametinib—Dermatitis—Methazolamide—glaucoma	0.00054	0.00123	CcSEcCtD
Trametinib—Eye disorder—Clonidine—glaucoma	0.00054	0.00123	CcSEcCtD
Trametinib—Nausea—Carbachol—glaucoma	0.000539	0.00123	CcSEcCtD
Trametinib—Infection—Travoprost—glaucoma	0.000538	0.00123	CcSEcCtD
Trametinib—Headache—Methazolamide—glaucoma	0.000537	0.00123	CcSEcCtD
Trametinib—Cardiac disorder—Clonidine—glaucoma	0.000536	0.00123	CcSEcCtD
Trametinib—Arthralgia—Pilocarpine—glaucoma	0.000536	0.00123	CcSEcCtD
Trametinib—Myalgia—Pilocarpine—glaucoma	0.000536	0.00123	CcSEcCtD
Trametinib—Nausea—Levobunolol—glaucoma	0.000531	0.00122	CcSEcCtD
Trametinib—Infection—Brinzolamide—glaucoma	0.000531	0.00121	CcSEcCtD
Trametinib—Nervous system disorder—Travoprost—glaucoma	0.000531	0.00121	CcSEcCtD
Trametinib—Epistaxis—Betaxolol—glaucoma	0.000528	0.00121	CcSEcCtD
Trametinib—Skin disorder—Travoprost—glaucoma	0.000526	0.0012	CcSEcCtD
Trametinib—Hyperhidrosis—Dorzolamide—glaucoma	0.000526	0.0012	CcSEcCtD
Trametinib—Abdominal pain—Apraclonidine—glaucoma	0.000524	0.0012	CcSEcCtD
Trametinib—Nervous system disorder—Brinzolamide—glaucoma	0.000524	0.0012	CcSEcCtD
Trametinib—Angiopathy—Clonidine—glaucoma	0.000524	0.0012	CcSEcCtD
Trametinib—Rash—Latanoprost—glaucoma	0.000523	0.0012	CcSEcCtD
Trametinib—Dermatitis—Latanoprost—glaucoma	0.000522	0.0012	CcSEcCtD
Trametinib—Mediastinal disorder—Clonidine—glaucoma	0.00052	0.00119	CcSEcCtD
Trametinib—Headache—Latanoprost—glaucoma	0.00052	0.00119	CcSEcCtD
Trametinib—Skin disorder—Brinzolamide—glaucoma	0.000519	0.00119	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000519	0.00119	CcSEcCtD
Trametinib—Arrhythmia—Clonidine—glaucoma	0.000516	0.00118	CcSEcCtD
Trametinib—Decreased appetite—Acetazolamide—glaucoma	0.000516	0.00118	CcSEcCtD
Trametinib—Insomnia—Brimonidine—glaucoma	0.000515	0.00118	CcSEcCtD
Trametinib—Oedema—Pilocarpine—glaucoma	0.000514	0.00118	CcSEcCtD
Trametinib—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000512	0.00117	CcSEcCtD
Trametinib—Bradycardia—Betaxolol—glaucoma	0.000512	0.00117	CcSEcCtD
Trametinib—Fatigue—Acetazolamide—glaucoma	0.000511	0.00117	CcSEcCtD
Trametinib—Infection—Pilocarpine—glaucoma	0.00051	0.00117	CcSEcCtD
Trametinib—Nausea—Methazolamide—glaucoma	0.000509	0.00116	CcSEcCtD
Trametinib—Mental disorder—Clonidine—glaucoma	0.000506	0.00116	CcSEcCtD
Trametinib—Thrombocytopenia—Pilocarpine—glaucoma	0.000503	0.00115	CcSEcCtD
Trametinib—Erythema—Clonidine—glaucoma	0.000503	0.00115	CcSEcCtD
Trametinib—Hyperhidrosis—Pilocarpine—glaucoma	0.000497	0.00114	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000495	0.00113	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Travoprost—glaucoma	0.000493	0.00113	CcSEcCtD
Trametinib—Insomnia—Dorzolamide—glaucoma	0.000492	0.00112	CcSEcCtD
Trametinib—Gastrointestinal disorder—Brimonidine—glaucoma	0.000491	0.00112	CcSEcCtD
Trametinib—Fatigue—Brimonidine—glaucoma	0.000491	0.00112	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000487	0.00111	CcSEcCtD
Trametinib—Insomnia—Brinzolamide—glaucoma	0.000483	0.00111	CcSEcCtD
Trametinib—Muscle spasms—Clonidine—glaucoma	0.000483	0.00111	CcSEcCtD
Trametinib—Asthenia—Apraclonidine—glaucoma	0.000476	0.00109	CcSEcCtD
Trametinib—Vision blurred—Clonidine—glaucoma	0.000474	0.00108	CcSEcCtD
Trametinib—Decreased appetite—Dorzolamide—glaucoma	0.000473	0.00108	CcSEcCtD
Trametinib—Eye disorder—Betaxolol—glaucoma	0.00047	0.00107	CcSEcCtD
Trametinib—Pruritus—Apraclonidine—glaucoma	0.000469	0.00107	CcSEcCtD
Trametinib—Body temperature increased—Acetazolamide—glaucoma	0.000469	0.00107	CcSEcCtD
Trametinib—Fatigue—Dorzolamide—glaucoma	0.000469	0.00107	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000468	0.00107	CcSEcCtD
Trametinib—Gastrointestinal disorder—Travoprost—glaucoma	0.000467	0.00107	CcSEcCtD
Trametinib—Fatigue—Travoprost—glaucoma	0.000467	0.00107	CcSEcCtD
Trametinib—Cardiac disorder—Betaxolol—glaucoma	0.000467	0.00107	CcSEcCtD
Trametinib—Insomnia—Pilocarpine—glaucoma	0.000465	0.00106	CcSEcCtD
Trametinib—Decreased appetite—Brinzolamide—glaucoma	0.000465	0.00106	CcSEcCtD
Trametinib—Constipation—Travoprost—glaucoma	0.000463	0.00106	CcSEcCtD
Trametinib—Hyperglycaemia—Timolol—glaucoma	0.000463	0.00106	CcSEcCtD
Trametinib—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000461	0.00106	CcSEcCtD
Trametinib—Asthenia—Bimatoprost—glaucoma	0.000461	0.00106	CcSEcCtD
Trametinib—Fatigue—Brinzolamide—glaucoma	0.000461	0.00105	CcSEcCtD
Trametinib—Angiopathy—Betaxolol—glaucoma	0.000456	0.00104	CcSEcCtD
Trametinib—Pruritus—Bimatoprost—glaucoma	0.000455	0.00104	CcSEcCtD
Trametinib—Diarrhoea—Apraclonidine—glaucoma	0.000454	0.00104	CcSEcCtD
Trametinib—Mediastinal disorder—Betaxolol—glaucoma	0.000453	0.00104	CcSEcCtD
Trametinib—Chills—Betaxolol—glaucoma	0.000451	0.00103	CcSEcCtD
Trametinib—Arrhythmia—Betaxolol—glaucoma	0.000449	0.00103	CcSEcCtD
Trametinib—Decreased appetite—Pilocarpine—glaucoma	0.000447	0.00102	CcSEcCtD
Trametinib—Gastrointestinal pain—Dorzolamide—glaucoma	0.000445	0.00102	CcSEcCtD
Trametinib—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000443	0.00101	CcSEcCtD
Trametinib—Gastrointestinal pain—Travoprost—glaucoma	0.000443	0.00101	CcSEcCtD
Trametinib—Mental disorder—Betaxolol—glaucoma	0.00044	0.00101	CcSEcCtD
Trametinib—Constipation—Pilocarpine—glaucoma	0.000439	0.001	CcSEcCtD
Trametinib—Cough—Clonidine—glaucoma	0.000439	0.001	CcSEcCtD
Trametinib—Dizziness—Apraclonidine—glaucoma	0.000438	0.001	CcSEcCtD
Trametinib—Malnutrition—Betaxolol—glaucoma	0.000438	0.001	CcSEcCtD
Trametinib—Erythema—Betaxolol—glaucoma	0.000438	0.001	CcSEcCtD
Trametinib—Epistaxis—Timolol—glaucoma	0.000431	0.000987	CcSEcCtD
Trametinib—Abdominal pain—Dorzolamide—glaucoma	0.00043	0.000983	CcSEcCtD
Trametinib—Body temperature increased—Dorzolamide—glaucoma	0.00043	0.000983	CcSEcCtD
Trametinib—Dysgeusia—Betaxolol—glaucoma	0.000429	0.00098	CcSEcCtD
Trametinib—Arthralgia—Clonidine—glaucoma	0.000428	0.000979	CcSEcCtD
Trametinib—Abdominal pain—Travoprost—glaucoma	0.000428	0.000979	CcSEcCtD
Trametinib—Asthenia—Acetazolamide—glaucoma	0.000426	0.000973	CcSEcCtD
Trametinib—Dizziness—Bimatoprost—glaucoma	0.000425	0.000972	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000425	0.000972	CcSEcCtD
Trametinib—Vomiting—Apraclonidine—glaucoma	0.000422	0.000964	CcSEcCtD
Trametinib—Muscle spasms—Betaxolol—glaucoma	0.000421	0.000962	CcSEcCtD
Trametinib—Gastrointestinal pain—Pilocarpine—glaucoma	0.00042	0.000961	CcSEcCtD
Trametinib—Dry mouth—Clonidine—glaucoma	0.000418	0.000957	CcSEcCtD
Trametinib—Bradycardia—Timolol—glaucoma	0.000418	0.000956	CcSEcCtD
Trametinib—Dermatitis—Apraclonidine—glaucoma	0.000418	0.000955	CcSEcCtD
Trametinib—Headache—Apraclonidine—glaucoma	0.000415	0.00095	CcSEcCtD
Trametinib—Vision blurred—Betaxolol—glaucoma	0.000412	0.000943	CcSEcCtD
Trametinib—Oedema—Clonidine—glaucoma	0.00041	0.000938	CcSEcCtD
Trametinib—Asthenia—Brimonidine—glaucoma	0.000408	0.000934	CcSEcCtD
Trametinib—Infection—Clonidine—glaucoma	0.000408	0.000932	CcSEcCtD
Trametinib—Body temperature increased—Pilocarpine—glaucoma	0.000406	0.000929	CcSEcCtD
Trametinib—Abdominal pain—Pilocarpine—glaucoma	0.000406	0.000929	CcSEcCtD
Trametinib—Diarrhoea—Acetazolamide—glaucoma	0.000406	0.000928	CcSEcCtD
Trametinib—Rash—Bimatoprost—glaucoma	0.000405	0.000927	CcSEcCtD
Trametinib—Dermatitis—Bimatoprost—glaucoma	0.000405	0.000926	CcSEcCtD
Trametinib—Oedema peripheral—Timolol—glaucoma	0.000405	0.000925	CcSEcCtD
Trametinib—Anaemia—Betaxolol—glaucoma	0.000404	0.000925	CcSEcCtD
Trametinib—Connective tissue disorder—Timolol—glaucoma	0.000404	0.000923	CcSEcCtD
Trametinib—Pruritus—Brimonidine—glaucoma	0.000403	0.000921	CcSEcCtD
Trametinib—Headache—Bimatoprost—glaucoma	0.000403	0.000921	CcSEcCtD
Trametinib—Nervous system disorder—Clonidine—glaucoma	0.000402	0.00092	CcSEcCtD
Trametinib—Thrombocytopenia—Clonidine—glaucoma	0.000402	0.000919	CcSEcCtD
Trametinib—Skin disorder—Clonidine—glaucoma	0.000398	0.000911	CcSEcCtD
Trametinib—Hyperhidrosis—Clonidine—glaucoma	0.000397	0.000907	CcSEcCtD
Trametinib—Nausea—Apraclonidine—glaucoma	0.000394	0.000901	CcSEcCtD
Trametinib—Dizziness—Acetazolamide—glaucoma	0.000392	0.000897	CcSEcCtD
Trametinib—Asthenia—Dorzolamide—glaucoma	0.00039	0.000892	CcSEcCtD
Trametinib—Asthenia—Travoprost—glaucoma	0.000388	0.000888	CcSEcCtD
Trametinib—Pruritus—Dorzolamide—glaucoma	0.000385	0.00088	CcSEcCtD
Trametinib—Eye disorder—Timolol—glaucoma	0.000384	0.000878	CcSEcCtD
Trametinib—Asthenia—Brinzolamide—glaucoma	0.000383	0.000877	CcSEcCtD
Trametinib—Pruritus—Travoprost—glaucoma	0.000383	0.000876	CcSEcCtD
Trametinib—Cough—Betaxolol—glaucoma	0.000382	0.000873	CcSEcCtD
Trametinib—Nausea—Bimatoprost—glaucoma	0.000382	0.000873	CcSEcCtD
Trametinib—Cardiac disorder—Timolol—glaucoma	0.000381	0.000872	CcSEcCtD
Trametinib—Pruritus—Brinzolamide—glaucoma	0.000378	0.000865	CcSEcCtD
Trametinib—Vomiting—Acetazolamide—glaucoma	0.000377	0.000863	CcSEcCtD
Trametinib—Dizziness—Brimonidine—glaucoma	0.000376	0.000861	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Clonidine—glaucoma	0.000374	0.000855	CcSEcCtD
Trametinib—Angiopathy—Timolol—glaucoma	0.000373	0.000852	CcSEcCtD
Trametinib—Myalgia—Betaxolol—glaucoma	0.000373	0.000852	CcSEcCtD
Trametinib—Arthralgia—Betaxolol—glaucoma	0.000373	0.000852	CcSEcCtD
Trametinib—Diarrhoea—Dorzolamide—glaucoma	0.000372	0.000851	CcSEcCtD
Trametinib—Headache—Acetazolamide—glaucoma	0.000372	0.00085	CcSEcCtD
Trametinib—Insomnia—Clonidine—glaucoma	0.000371	0.000849	CcSEcCtD
Trametinib—Diarrhoea—Travoprost—glaucoma	0.00037	0.000847	CcSEcCtD
Trametinib—Mediastinal disorder—Timolol—glaucoma	0.00037	0.000847	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00037	0.000846	CcSEcCtD
Trametinib—Asthenia—Pilocarpine—glaucoma	0.000369	0.000843	CcSEcCtD
Trametinib—Arrhythmia—Timolol—glaucoma	0.000367	0.000839	CcSEcCtD
Trametinib—Diarrhoea—Brinzolamide—glaucoma	0.000366	0.000836	CcSEcCtD
Trametinib—Dry mouth—Betaxolol—glaucoma	0.000364	0.000833	CcSEcCtD
Trametinib—Pruritus—Pilocarpine—glaucoma	0.000363	0.000831	CcSEcCtD
Trametinib—Mental disorder—Timolol—glaucoma	0.00036	0.000823	CcSEcCtD
Trametinib—Dizziness—Dorzolamide—glaucoma	0.000359	0.000822	CcSEcCtD
Trametinib—Rash—Brimonidine—glaucoma	0.000359	0.000821	CcSEcCtD
Trametinib—Dermatitis—Brimonidine—glaucoma	0.000359	0.00082	CcSEcCtD
Trametinib—Dizziness—Travoprost—glaucoma	0.000358	0.000819	CcSEcCtD
Trametinib—Erythema—Timolol—glaucoma	0.000357	0.000818	CcSEcCtD
Trametinib—Malnutrition—Timolol—glaucoma	0.000357	0.000818	CcSEcCtD
Trametinib—Oedema—Betaxolol—glaucoma	0.000357	0.000817	CcSEcCtD
Trametinib—Headache—Brimonidine—glaucoma	0.000357	0.000816	CcSEcCtD
Trametinib—Decreased appetite—Clonidine—glaucoma	0.000357	0.000816	CcSEcCtD
Trametinib—Infection—Betaxolol—glaucoma	0.000355	0.000812	CcSEcCtD
Trametinib—Gastrointestinal disorder—Clonidine—glaucoma	0.000354	0.00081	CcSEcCtD
Trametinib—Fatigue—Clonidine—glaucoma	0.000354	0.000809	CcSEcCtD
Trametinib—Dizziness—Brinzolamide—glaucoma	0.000353	0.000808	CcSEcCtD
Trametinib—Nausea—Acetazolamide—glaucoma	0.000352	0.000806	CcSEcCtD
Trametinib—Diarrhoea—Pilocarpine—glaucoma	0.000351	0.000804	CcSEcCtD
Trametinib—Constipation—Clonidine—glaucoma	0.000351	0.000802	CcSEcCtD
Trametinib—Nervous system disorder—Betaxolol—glaucoma	0.00035	0.000801	CcSEcCtD
Trametinib—Dysgeusia—Timolol—glaucoma	0.00035	0.000801	CcSEcCtD
Trametinib—Thrombocytopenia—Betaxolol—glaucoma	0.00035	0.0008	CcSEcCtD
Trametinib—Skin disorder—Betaxolol—glaucoma	0.000347	0.000794	CcSEcCtD
Trametinib—Vomiting—Dorzolamide—glaucoma	0.000346	0.000791	CcSEcCtD
Trametinib—Hyperhidrosis—Betaxolol—glaucoma	0.000345	0.00079	CcSEcCtD
Trametinib—Rash—Dorzolamide—glaucoma	0.000343	0.000784	CcSEcCtD
Trametinib—Dermatitis—Dorzolamide—glaucoma	0.000342	0.000783	CcSEcCtD
Trametinib—Rash—Travoprost—glaucoma	0.000341	0.000781	CcSEcCtD
Trametinib—Dermatitis—Travoprost—glaucoma	0.000341	0.00078	CcSEcCtD
Trametinib—Headache—Dorzolamide—glaucoma	0.000341	0.000779	CcSEcCtD
Trametinib—Vomiting—Brinzolamide—glaucoma	0.00034	0.000777	CcSEcCtD
Trametinib—Dizziness—Pilocarpine—glaucoma	0.00034	0.000777	CcSEcCtD
Trametinib—Headache—Travoprost—glaucoma	0.000339	0.000776	CcSEcCtD
Trametinib—Nausea—Brimonidine—glaucoma	0.000338	0.000773	CcSEcCtD
Trametinib—Rash—Brinzolamide—glaucoma	0.000337	0.000771	CcSEcCtD
Trametinib—Vision blurred—Timolol—glaucoma	0.000337	0.000771	CcSEcCtD
Trametinib—Dermatitis—Brinzolamide—glaucoma	0.000337	0.00077	CcSEcCtD
Trametinib—Gastrointestinal pain—Clonidine—glaucoma	0.000335	0.000767	CcSEcCtD
Trametinib—Headache—Brinzolamide—glaucoma	0.000335	0.000766	CcSEcCtD
Trametinib—Vomiting—Pilocarpine—glaucoma	0.000327	0.000747	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000325	0.000744	CcSEcCtD
Trametinib—Body temperature increased—Clonidine—glaucoma	0.000324	0.000742	CcSEcCtD
Trametinib—Abdominal pain—Clonidine—glaucoma	0.000324	0.000742	CcSEcCtD
Trametinib—Rash—Pilocarpine—glaucoma	0.000324	0.000741	CcSEcCtD
Trametinib—Dermatitis—Pilocarpine—glaucoma	0.000324	0.00074	CcSEcCtD
Trametinib—Insomnia—Betaxolol—glaucoma	0.000323	0.000739	CcSEcCtD
Trametinib—Nausea—Dorzolamide—glaucoma	0.000323	0.000739	CcSEcCtD
Trametinib—Headache—Pilocarpine—glaucoma	0.000322	0.000736	CcSEcCtD
Trametinib—Nausea—Travoprost—glaucoma	0.000322	0.000735	CcSEcCtD
Trametinib—Nausea—Brinzolamide—glaucoma	0.000317	0.000726	CcSEcCtD
Trametinib—Cough—Timolol—glaucoma	0.000312	0.000714	CcSEcCtD
Trametinib—Decreased appetite—Betaxolol—glaucoma	0.00031	0.00071	CcSEcCtD
Trametinib—Hypertension—Timolol—glaucoma	0.000309	0.000706	CcSEcCtD
Trametinib—Gastrointestinal disorder—Betaxolol—glaucoma	0.000308	0.000705	CcSEcCtD
Trametinib—Fatigue—Betaxolol—glaucoma	0.000308	0.000704	CcSEcCtD
Trametinib—Constipation—Betaxolol—glaucoma	0.000305	0.000699	CcSEcCtD
Trametinib—Nausea—Pilocarpine—glaucoma	0.000305	0.000698	CcSEcCtD
Trametinib—Arthralgia—Timolol—glaucoma	0.000304	0.000696	CcSEcCtD
Trametinib—Myalgia—Timolol—glaucoma	0.000304	0.000696	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000302	0.000691	CcSEcCtD
Trametinib—Dry mouth—Timolol—glaucoma	0.000298	0.000681	CcSEcCtD
Trametinib—Asthenia—Clonidine—glaucoma	0.000294	0.000673	CcSEcCtD
Trametinib—Oedema—Timolol—glaucoma	0.000292	0.000667	CcSEcCtD
Trametinib—Pruritus—Clonidine—glaucoma	0.00029	0.000664	CcSEcCtD
Trametinib—Infection—Timolol—glaucoma	0.00029	0.000663	CcSEcCtD
Trametinib—Nervous system disorder—Timolol—glaucoma	0.000286	0.000655	CcSEcCtD
Trametinib—Skin disorder—Timolol—glaucoma	0.000283	0.000648	CcSEcCtD
Trametinib—Body temperature increased—Betaxolol—glaucoma	0.000282	0.000646	CcSEcCtD
Trametinib—Hyperhidrosis—Timolol—glaucoma	0.000282	0.000645	CcSEcCtD
Trametinib—Diarrhoea—Clonidine—glaucoma	0.000281	0.000642	CcSEcCtD
Trametinib—Dizziness—Clonidine—glaucoma	0.000271	0.000621	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Timolol—glaucoma	0.000266	0.000608	CcSEcCtD
Trametinib—Insomnia—Timolol—glaucoma	0.000264	0.000604	CcSEcCtD
Trametinib—Vomiting—Clonidine—glaucoma	0.000261	0.000597	CcSEcCtD
Trametinib—Rash—Clonidine—glaucoma	0.000259	0.000592	CcSEcCtD
Trametinib—Dermatitis—Clonidine—glaucoma	0.000258	0.000591	CcSEcCtD
Trametinib—Headache—Clonidine—glaucoma	0.000257	0.000588	CcSEcCtD
Trametinib—Asthenia—Betaxolol—glaucoma	0.000256	0.000586	CcSEcCtD
Trametinib—Decreased appetite—Timolol—glaucoma	0.000254	0.00058	CcSEcCtD
Trametinib—Pruritus—Betaxolol—glaucoma	0.000253	0.000578	CcSEcCtD
Trametinib—Gastrointestinal disorder—Timolol—glaucoma	0.000252	0.000576	CcSEcCtD
Trametinib—Fatigue—Timolol—glaucoma	0.000252	0.000575	CcSEcCtD
Trametinib—Diarrhoea—Betaxolol—glaucoma	0.000244	0.000559	CcSEcCtD
Trametinib—Nausea—Clonidine—glaucoma	0.000244	0.000557	CcSEcCtD
Trametinib—Gastrointestinal pain—Timolol—glaucoma	0.000239	0.000546	CcSEcCtD
Trametinib—Dizziness—Betaxolol—glaucoma	0.000236	0.00054	CcSEcCtD
Trametinib—MAP2K2—Focal Adhesion—FN1—glaucoma	0.000234	0.000805	CbGpPWpGaD
Trametinib—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	0.000233	0.000801	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—NTRK1—glaucoma	0.000232	0.000801	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—BAD—glaucoma	0.000231	0.000795	CbGpPWpGaD
Trametinib—Body temperature increased—Timolol—glaucoma	0.000231	0.000528	CcSEcCtD
Trametinib—Abdominal pain—Timolol—glaucoma	0.000231	0.000528	CcSEcCtD
Trametinib—MAP2K1—Focal Adhesion—CAV1—glaucoma	0.00023	0.000791	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—BAD—glaucoma	0.000229	0.000788	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—BAD—glaucoma	0.000229	0.000788	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000229	0.000788	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LRP12—glaucoma	0.000227	0.000783	CbGpPWpGaD
Trametinib—Vomiting—Betaxolol—glaucoma	0.000227	0.000519	CcSEcCtD
Trametinib—MAP2K1—Signaling by EGFR—BAD—glaucoma	0.000227	0.000781	CbGpPWpGaD
Trametinib—Rash—Betaxolol—glaucoma	0.000225	0.000515	CcSEcCtD
Trametinib—Dermatitis—Betaxolol—glaucoma	0.000225	0.000515	CcSEcCtD
Trametinib—MAP2K1—Signaling by GPCR—PTGFR—glaucoma	0.000225	0.000774	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—BAD—glaucoma	0.000225	0.000774	CbGpPWpGaD
Trametinib—Headache—Betaxolol—glaucoma	0.000224	0.000512	CcSEcCtD
Trametinib—MAP2K1—Signaling by PDGF—BAD—glaucoma	0.000224	0.00077	CbGpPWpGaD
Trametinib—MAP2K1—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000223	0.000768	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000222	0.000765	CbGpPWpGaD
Trametinib—MAP2K2—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.00022	0.000759	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CTSA—glaucoma	0.000219	0.000756	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—FN1—glaucoma	0.000219	0.000753	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000216	0.000746	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—BAD—glaucoma	0.000216	0.000744	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000215	0.000741	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LRP12—glaucoma	0.000213	0.000733	CbGpPWpGaD
Trametinib—Nausea—Betaxolol—glaucoma	0.000212	0.000485	CcSEcCtD
Trametinib—MAP2K2—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000212	0.000729	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—NOS3—glaucoma	0.000211	0.000727	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—PAX6—glaucoma	0.000209	0.000722	CbGpPWpGaD
Trametinib—Asthenia—Timolol—glaucoma	0.000209	0.000479	CcSEcCtD
Trametinib—MAP2K2—Disease—HEYL—glaucoma	0.000209	0.000721	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGFR1OP—glaucoma	0.000209	0.000721	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—IL1A—glaucoma	0.000208	0.000716	CbGpPWpGaD
Trametinib—Pruritus—Timolol—glaucoma	0.000206	0.000472	CcSEcCtD
Trametinib—MAP2K1—MicroRNAs in cardiomyocyte hypertrophy—TNF—glaucoma	0.000206	0.00071	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CTSA—glaucoma	0.000205	0.000707	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000204	0.000703	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000202	0.000698	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—NGF—glaucoma	0.000202	0.000695	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by VEGF—VEGFA—glaucoma	0.0002	0.000688	CbGpPWpGaD
Trametinib—Diarrhoea—Timolol—glaucoma	0.0002	0.000457	CcSEcCtD
Trametinib—MAP2K1—VEGFA-VEGFR2 Pathway—VEGFA—glaucoma	0.000198	0.000682	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways in Glioblastoma—TP53—glaucoma	0.000198	0.000682	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—NOS3—glaucoma	0.000197	0.00068	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—PAX6—glaucoma	0.000196	0.000675	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HEYL—glaucoma	0.000196	0.000674	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGFR1OP—glaucoma	0.000196	0.000674	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000195	0.000673	CbGpPWpGaD
Trametinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000194	0.000669	CbGpPWpGaD
Trametinib—Dizziness—Timolol—glaucoma	0.000193	0.000441	CcSEcCtD
Trametinib—MAP2K2—Signaling by ERBB4—CDKN1B—glaucoma	0.000192	0.000662	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—CYP1B1—glaucoma	0.000192	0.000662	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000191	0.000658	CbGpPWpGaD
Trametinib—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	0.000189	0.000653	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—MMP9—glaucoma	0.000189	0.000651	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—NGF—glaucoma	0.000189	0.000651	CbGpPWpGaD
Trametinib—MAP2K2—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000188	0.000649	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—VEGFA—glaucoma	0.000187	0.000644	CbGpPWpGaD
Trametinib—Vomiting—Timolol—glaucoma	0.000185	0.000424	CcSEcCtD
Trametinib—MAP2K1—Signaling Pathways in Glioblastoma—TP53—glaucoma	0.000185	0.000638	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TXNIP—glaucoma	0.000185	0.000636	CbGpPWpGaD
Trametinib—Rash—Timolol—glaucoma	0.000184	0.000421	CcSEcCtD
Trametinib—Dermatitis—Timolol—glaucoma	0.000184	0.00042	CcSEcCtD
Trametinib—MAP2K2—Downstream signal transduction—CDKN1B—glaucoma	0.000184	0.000632	CbGpPWpGaD
Trametinib—Headache—Timolol—glaucoma	0.000183	0.000418	CcSEcCtD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000183	0.00063	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—CDKN1B—glaucoma	0.000183	0.000629	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—CDKN1B—glaucoma	0.000182	0.000626	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TBK1—glaucoma	0.000181	0.000624	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—CDKN1B—glaucoma	0.000181	0.000623	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—CDKN1B—glaucoma	0.00018	0.00062	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000179	0.000618	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—MMP9—glaucoma	0.000177	0.000609	CbGpPWpGaD
Trametinib—MAP2K1—Toll-like Receptor Signaling Pathway—TNF—glaucoma	0.000176	0.000608	CbGpPWpGaD
Trametinib—Nausea—Timolol—glaucoma	0.000173	0.000396	CcSEcCtD
Trametinib—MAP2K1—Immune System—TXNIP—glaucoma	0.000173	0.000595	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—CDKN1B—glaucoma	0.000172	0.000592	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—CDKN1B—glaucoma	0.000171	0.000589	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—CDKN1B—glaucoma	0.00017	0.000586	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—CDKN1B—glaucoma	0.00017	0.000586	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.00017	0.000586	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—CDKN1B—glaucoma	0.00017	0.000586	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TBK1—glaucoma	0.000169	0.000584	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—CDKN1B—glaucoma	0.000169	0.000583	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NARFL—glaucoma	0.000169	0.000582	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CA5A—glaucoma	0.000169	0.000582	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—CDKN1B—glaucoma	0.000169	0.000581	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000167	0.000576	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—BAD—glaucoma	0.000166	0.000573	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—CDKN1B—glaucoma	0.000166	0.000573	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—C1QB—glaucoma	0.000164	0.000564	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—CDKN1B—glaucoma	0.000159	0.000549	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000159	0.000549	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000159	0.000549	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000158	0.000545	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—CDKN1B—glaucoma	0.000158	0.000544	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—OPN4—glaucoma	0.000158	0.000543	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000156	0.000539	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—BAD—glaucoma	0.000156	0.000537	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—CDKN1B—glaucoma	0.000156	0.000536	CbGpPWpGaD
Trametinib—CYP2C8—Biological oxidations—GSTM1—glaucoma	0.000154	0.000529	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—C1QB—glaucoma	0.000153	0.000528	CbGpPWpGaD
Trametinib—MAP2K1—Senescence and Autophagy in Cancer—TP53—glaucoma	0.000152	0.000523	CbGpPWpGaD
Trametinib—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	0.000151	0.000522	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000151	0.000519	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00015	0.000516	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—OPN4—glaucoma	0.000147	0.000508	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000147	0.000507	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HEYL—glaucoma	0.000146	0.000505	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—TXN—glaucoma	0.000146	0.000503	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTGFR—glaucoma	0.000142	0.000489	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000141	0.000486	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—TNF—glaucoma	0.000138	0.000474	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HEYL—glaucoma	0.000137	0.000472	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—TXN—glaucoma	0.000137	0.000471	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—glaucoma	0.000135	0.000466	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—VEGFA—glaucoma	0.000134	0.000461	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTGFR—glaucoma	0.000133	0.000457	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HDAC9—glaucoma	0.000131	0.00045	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000129	0.000446	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—MMP2—glaucoma	0.000129	0.000445	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—glaucoma	0.000126	0.000436	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TNF—glaucoma	0.000126	0.000436	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—VEGFA—glaucoma	0.000125	0.000431	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000125	0.000429	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HDAC9—glaucoma	0.000122	0.000421	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—SMO—glaucoma	0.000121	0.000417	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—MMP2—glaucoma	0.000121	0.000417	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TNF—glaucoma	0.000118	0.000408	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—CDKN1B—glaucoma	0.000116	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—SMO—glaucoma	0.000113	0.00039	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—glaucoma	0.000111	0.000384	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RPTOR—glaucoma	0.000111	0.000383	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—C3—glaucoma	0.000109	0.000377	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—CDKN1B—glaucoma	0.000108	0.000374	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NCK2—glaucoma	0.000108	0.000371	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000107	0.000368	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—BCL2L1—glaucoma	0.000105	0.000361	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—glaucoma	0.000104	0.000359	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RPTOR—glaucoma	0.000104	0.000358	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—CYP1B1—glaucoma	0.000103	0.000355	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—C3—glaucoma	0.000102	0.000353	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	0.000102	0.00035	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NCK2—glaucoma	0.000101	0.000347	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—BCL2L1—glaucoma	9.8e-05	0.000338	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—MMP9—glaucoma	9.72e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—BAD—glaucoma	9.49e-05	0.000327	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.41e-05	0.000324	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—MMP2—glaucoma	9.22e-05	0.000318	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HDAC9—glaucoma	9.14e-05	0.000315	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—MMP9—glaucoma	9.09e-05	0.000313	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA5A—glaucoma	9.07e-05	0.000312	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NARFL—glaucoma	9.07e-05	0.000312	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—BAD—glaucoma	8.88e-05	0.000306	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—VEGFA—glaucoma	8.72e-05	0.000301	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—MMP2—glaucoma	8.63e-05	0.000297	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HDAC9—glaucoma	8.55e-05	0.000295	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CA1—glaucoma	8.25e-05	0.000284	CbGpPWpGaD
Trametinib—CYP3A4—Biological oxidations—GSTM1—glaucoma	8.24e-05	0.000284	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—VEGFA—glaucoma	8.16e-05	0.000281	CbGpPWpGaD
Trametinib—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	8.13e-05	0.00028	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CTSA—glaucoma	7.99e-05	0.000275	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—EDN1—glaucoma	7.98e-05	0.000275	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CA2—glaucoma	7.54e-05	0.00026	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—EDN1—glaucoma	7.47e-05	0.000257	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.37e-05	0.000254	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.37e-05	0.000254	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1A—glaucoma	7.25e-05	0.00025	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SMO—glaucoma	7.15e-05	0.000247	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN2B—glaucoma	7.02e-05	0.000242	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—C3—glaucoma	6.98e-05	0.00024	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—MMP9—glaucoma	6.93e-05	0.000239	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1A—glaucoma	6.79e-05	0.000234	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SMO—glaucoma	6.69e-05	0.000231	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CDKN1B—glaucoma	6.61e-05	0.000228	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN2B—glaucoma	6.57e-05	0.000226	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NTRK2—glaucoma	6.54e-05	0.000225	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—C3—glaucoma	6.53e-05	0.000225	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—MMP9—glaucoma	6.49e-05	0.000224	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—C3—glaucoma	6.37e-05	0.00022	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—VEGFA—glaucoma	6.23e-05	0.000215	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CDKN1B—glaucoma	6.19e-05	0.000213	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NTRK2—glaucoma	6.12e-05	0.000211	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BCL2L1—glaucoma	6.1e-05	0.00021	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—C3—glaucoma	5.96e-05	0.000205	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTHFR—glaucoma	5.88e-05	0.000203	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—VEGFA—glaucoma	5.82e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BCL2L1—glaucoma	5.71e-05	0.000197	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGFR—glaucoma	5.61e-05	0.000193	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—BAD—glaucoma	5.53e-05	0.000191	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTHFR—glaucoma	5.51e-05	0.00019	CbGpPWpGaD
Trametinib—MAP2K2—Disease—APOE—glaucoma	5.48e-05	0.000189	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CAV1—glaucoma	5.43e-05	0.000187	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—TNF—glaucoma	5.34e-05	0.000184	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NTRK1—glaucoma	5.33e-05	0.000184	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—TXN—glaucoma	5.32e-05	0.000183	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGFR—glaucoma	5.25e-05	0.000181	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—BAD—glaucoma	5.17e-05	0.000178	CbGpPWpGaD
Trametinib—MAP2K1—Disease—APOE—glaucoma	5.13e-05	0.000177	CbGpPWpGaD
Trametinib—MAP2K2—Disease—BAD—glaucoma	5.1e-05	0.000176	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CAV1—glaucoma	5.08e-05	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—TNF—glaucoma	4.99e-05	0.000172	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NTRK1—glaucoma	4.99e-05	0.000172	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN2B—glaucoma	4.92e-05	0.000169	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.85e-05	0.000167	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.81e-05	0.000166	CbGpPWpGaD
Trametinib—MAP2K1—Disease—BAD—glaucoma	4.78e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EDN1—glaucoma	4.72e-05	0.000163	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN2B—glaucoma	4.6e-05	0.000158	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA1—glaucoma	4.43e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EDN1—glaucoma	4.41e-05	0.000152	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NGF—glaucoma	4.33e-05	0.000149	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CTSA—glaucoma	4.29e-05	0.000148	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTT1—glaucoma	4.12e-05	0.000142	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—C3—glaucoma	4.12e-05	0.000142	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOS3—glaucoma	4.1e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NGF—glaucoma	4.06e-05	0.00014	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CA2—glaucoma	4.05e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—C3—glaucoma	3.86e-05	0.000133	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDKN1B—glaucoma	3.85e-05	0.000133	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—glaucoma	3.84e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—glaucoma	3.84e-05	0.000132	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CAV1—glaucoma	3.8e-05	0.000131	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—glaucoma	3.75e-05	0.000129	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FN1—glaucoma	3.62e-05	0.000125	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDKN1B—glaucoma	3.6e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—glaucoma	3.59e-05	0.000124	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—BAD—glaucoma	3.57e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CAV1—glaucoma	3.56e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CDKN1B—glaucoma	3.56e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—glaucoma	3.51e-05	0.000121	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FN1—glaucoma	3.38e-05	0.000117	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—BAD—glaucoma	3.34e-05	0.000115	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CDKN1B—glaucoma	3.33e-05	0.000115	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.32e-05	0.000115	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP1B1—glaucoma	3.28e-05	0.000113	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ABCA1—glaucoma	3.28e-05	0.000113	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—glaucoma	2.87e-05	9.9e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—TXN—glaucoma	2.85e-05	9.83e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—glaucoma	2.69e-05	9.26e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GSTM1—glaucoma	2.63e-05	9.05e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CDKN1B—glaucoma	2.49e-05	8.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CDKN1B—glaucoma	2.33e-05	8.03e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—glaucoma	2.32e-05	7.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—glaucoma	2.31e-05	7.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTT1—glaucoma	2.21e-05	7.62e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—glaucoma	2.16e-05	7.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—glaucoma	2.16e-05	7.43e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAV1—glaucoma	2.14e-05	7.37e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—VEGFA—glaucoma	2.07e-05	7.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—VEGFA—glaucoma	1.94e-05	6.67e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP1B1—glaucoma	1.76e-05	6.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ABCA1—glaucoma	1.76e-05	6.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—glaucoma	1.62e-05	5.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—glaucoma	1.56e-05	5.39e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—glaucoma	1.48e-05	5.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—glaucoma	1.46e-05	5.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GSTM1—glaucoma	1.41e-05	4.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—glaucoma	1.25e-05	4.29e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—glaucoma	1.16e-05	3.99e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAV1—glaucoma	1.15e-05	3.96e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—glaucoma	8.69e-06	2.99e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—glaucoma	7.94e-06	2.74e-05	CbGpPWpGaD
